Pharmacological intervention in hepatic stellate cell activation and hepatic fibrosis
The activation and transdifferentiation of hepatic stellate cells (HSCs) into contractile, matrix-producing myofibroblasts (MFBs) are central events in hepatic fibrogenesis. These processes are driven by autocrine- and paracrine-acting soluble factors (i.e. cytokines and chemokines). Proof-of-concep...
Main Authors: | Hans-Theo eSchon, Matthias eBartneck, Erawan eBorkham-Kamphorst, Jacob eNattermann, Twan eLammers, Frank eTacke, Ralf eWeiskirchen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00033/full |
Similar Items
-
The hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levels
by: Ralf eWeiskirchen, et al.
Published: (2015-05-01) -
PREDICTION OF EFFICIENCY OF PYROGENAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C
by: Chernyak S. A., et al.
Published: (2018-08-01) -
Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study
by: Yuzo Suzuki, et al.
Published: (2021-07-01) -
Towards accession of Russia to the Convention on Human Rights and Biomedicine
by: E. V. Tarasyants
Published: (2011-06-01) -
Understanding the mechanism of hepatic fibrosis and potential therapeutic approaches
by: Areeba Ahmad, et al.
Published: (2012-01-01)